In the first 2026 episode of Dispatched, we discuss perceptions, Australian health policy, highlighting newly accessible 2005 Cabinet papers and what they reveal about PBS reforms, generic pricing, pharmacy agreements and the influence of central agencies like Finance. They warn that today’s reviews, statutory pricing and cost-recovery debates must be viewed as an interconnected agenda.
Latest Video
New Stories
-
There is no negotiation, yet, so be careful not to give the impression of conceding anything
February 11, 2026 - - Latest News -
Arrotex and Pfizer forge strategic pharmacy partnership for ENBREL in Australia
February 11, 2026 - - Latest News -
Amplia expands U.S. footprint as AMPLICITY pancreatic cancer trial gains momentum
February 11, 2026 - - Australian Biotech -
Canine osteoarthritis study offers compelling translational evidence for PPS
February 11, 2026 - - Australian Biotech -
CSL presses ahead with transformation as earnings slip and leadership changes
February 11, 2026 - - Latest News -
This might be the real once-in-a-generation opportunity achieve reform
February 11, 2026 - - Latest News -
CSL confirms leadership transition as Gordon Naylor steps in as interim CEO
February 10, 2026 - - Latest News

